Thomas H Leung1, Emily R Snyder2, Yinghua Liu2, Jing Wang2, Seung K Kim3. 1. Department of Developmental Biology, Stanford University School of Medicine, Stanford, California 94305, USA; Department of Dermatology, Stanford University School of Medicine, Stanford, California 94305, USA; 2. Department of Developmental Biology, Stanford University School of Medicine, Stanford, California 94305, USA; 3. Department of Developmental Biology, Stanford University School of Medicine, Stanford, California 94305, USA; Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, California 94305, USA; Department of Medicine, Oncology Division, Stanford University School of Medicine, Stanford, California 94305, USA.
Abstract
Regenerative medicine aims to restore normal tissue architecture and function. However, the basis of tissue regeneration in mammalian solid organs remains undefined. Remarkably, mice lacking p21 fully regenerate injured ears without discernable scarring. Here we show that, in wild-type mice following tissue injury, stromal-derived factor-1 (Sdf1) is up-regulated in the wound epidermis and recruits Cxcr4-expressing leukocytes to the injury site. In p21-deficient mice, Sdf1 up-regulation and the subsequent recruitment of Cxcr4-expressing leukocytes are significantly diminished, thereby permitting scarless appendage regeneration. Lineage tracing demonstrates that this regeneration derives from fate-restricted progenitor cells. Pharmacological or genetic disruption of Sdf1-Cxcr4 signaling enhances tissue repair, including full reconstitution of tissue architecture and all cell types. Our findings identify signaling and cellular mechanisms underlying appendage regeneration in mice and suggest new therapeutic approaches for regenerative medicine.
Regenerative medicine aims to restore normal tissue architecture and function. However, the basis of tissue regeneration in mammalian solid organs remains undefined. Remarkably, mice lacking p21 fully regenerate injured ears without discernable scarring. Here we show that, in wild-type mice following tissue injury, stromal-derived factor-1 (Sdf1) is up-regulated in the wound epidermis and recruits Cxcr4-expressing leukocytes to the injury site. In p21-deficient mice, Sdf1 up-regulation and the subsequent recruitment of Cxcr4-expressing leukocytes are significantly diminished, thereby permitting scarless appendage regeneration. Lineage tracing demonstrates that this regeneration derives from fate-restricted progenitor cells. Pharmacological or genetic disruption of Sdf1-Cxcr4 signaling enhances tissue repair, including full reconstitution of tissue architecture and all cell types. Our findings identify signaling and cellular mechanisms underlying appendage regeneration in mice and suggest new therapeutic approaches for regenerative medicine.
In mammals, traumatic injuries typically heal with a fibroblast- and collagen-rich response, producing a fibrous scar rather than full reconstitution of cellular subtypes and functional tissue architecture. A central focus of regenerative and developmental biology is to restore normal tissue structure and function after injury. Astonishing examples of tissue and organ regeneration following injury include appendage and eye regeneration in amphibians and teleosts (Carlson 2007). Limited examples of tissue regeneration also exist in mammals, suggesting that mechanisms governing tissue regeneration may be evolutionarily conserved. Here, we investigated mouse ear regeneration to identify cellular, genetic, and signaling mechanisms driving mammalian appendage regeneration.Murphy-Roths-Large (MRL) mice and genetically related strains demonstrate enhanced tissue regeneration after injury to ears, cornea, digit tips, and the heart (Ueno et al. 2005; Chadwick et al. 2007; Edwards 2008). Histological analysis of MRL ear hole closure is reminiscent of ear regeneration observed in rabbits, cats, and other mammals. Improved ear regeneration has also been reported in mice lacking p21 (also known as Cdkn1a, Cip1, and Waf1). Similar to MRL mice, the molecular or cellular basis of ear regeneration in p21−/− mice has not been defined (Bedelbaeva et al. 2010). p21 protein is an established cyclin-dependent kinase (CDK) inhibitor and regulator of the cell cycle. Disruption of the cell cycle may explain the increased rate of ear hole closure, but mice lacking other cell cycle checkpoint regulators such as p53, p16, and Gadd45 did not improve ear hole regeneration (Arthur et al. 2010). Thus, we postulated that p21 cell cycle-independent functions may affect tissue regeneration. For example, p21 has been linked to the regulation of transcription, aging, cellular senescence, and cell reprogramming (Kippin 2005; Choudhury et al. 2007).From prior quantitative trait locus (QTL) mapping studies in MRL mice (Cheverud et al. 2012), we identified one locus linked to regenerative capacity that contained the gene for stromal cell-derived factor-1 (Sdf1; also known as Cxcl12). Sdf1 binds to the chemokine receptor Cxcr4, and increased Sdf1–Cxcr4 signaling has been linked to increased fibrosis and scar formation in multiple tissues, including the lung, liver, and heart. In zebrafish fin regeneration, overexpression of Sdf1 abrogated tissue regeneration (Dufourcq and Vriz 2006). In contrast, Cxcr4 loss-of-function mutations promoted hepatocyte regeneration in a liver injury model (Ding et al. 2014), and pharmacologic inhibition of Cxcr4 prevented lung fibrosis in a radiation- or bleomycin-induced injury model (Makino et al. 2013; Shu et al. 2013). Together, these results indicate that Sdf1 and Cxcr4 may play a role in appendage regeneration.The cellular basis for appendage regeneration in MRL and p21−/− mice also remains undefined. Lineage tracing studies in these mice have not been reported; thus, it is unknown whether appendage regeneration reflects development of an oligopotent progenitor or the collective action of multiple cell types with restricted cell fates that replace their own lineage. Organ regeneration in other animals involves activation of both mechanisms (Echeverri and Tanaka 2002; Gargioli and Slack 2004; Kragl et al. 2009; Lehoczky et al. 2011; Rinkevich et al. 2011; Tanaka and Reddien 2011; Stewart and Stankunas 2012; Sánchez Alvarado and Yamanaka 2014).In response to tissue injury in wild-type mice, we demonstrate here that wounded keratinocytes induce Sdf1, which recruits Cxcr4+ leukocytes to the injured area. In p21−/− mice, up-regulation of Sdf1 and the subsequent recruitment of Cxcr4-expressing leukocytes are significantly diminished, and appendage regeneration occurs. We show that pharmacological or conditional genetic disruption of Cxcr4 signaling and congenital leukopenia are conditions that promote tissue regeneration via lineage-restricted progenitor cells.
Results
Restriction of ectoderm and mesoderm fates in the regenerating ear
To assess the cellular origin of tissue regeneration in p21−/− mice, we performed cell lineage tracing. We confirmed that, in response to a 2-mm through-and-through ear puncture, the hole closed significantly better in p21−/− mice compared with wild-type mice (Fig. 1A,B). Hematoxylin and eosin (H&E) staining of vertical cross-sections taken from the rim of an injured wild-type ear revealed horizontally oriented fibroblasts and glassy thickened collagen, findings consistent with a sequence of wound healing, tissue fibrosis, and scar formation (Fig. 1C [for histology orientation], D,E). In contrast, the ears of p21−/− animals consistently revealed the presence of a bulbous mass of cells surrounded by a thickened epithelium, with large, striking epidermal protrusions into the dermis (Fig. 1E) and the appearance of chondrocyte regeneration (Fig. 1D, solid vertical lines). Taken together, these morphohistological changes have been previously associated with tissue regeneration and are consistent with prior observations in MRL mice (Clark et al. 1998; Rajnoch et al. 2003; Heber-Katz et al. 2004).
Figure 1.
Restriction of ectoderm fates in the regenerating ear. (A) Photographs of wounded wild-type and p21−/− mouse ears on days 0 and 28. Representative images were selected from each group. (B) The area of the wounded ear hole measured in wild-type and p21−/− mice on weeks 1, 2, 3, and 4. n = 12–14 mice per group. (*) P < 0.01. The experiment was performed four times independently. (C) Schematic for histology orientation. The red square represents a sample histology section. (D) H&E staining of vertical cross-sections taken from the rim of the wound hole in wild-type and p21−/− mice at day 28. Magnification, 2.5×. Solid vertical lines indicate the ends of the cartilage plate; broken lines demonstrate soft tissue borders. (E) H&E staining of vertical cross-sections taken from the rim of the wound hole in wild-type and p21−/− mice at day 14. (F) Vertical cross-sections of K14CreERmTmG appendages taken from the rim of the wound hole at baseline and 1–4 wk after injury for wild-type and p21−/− mice. GFP fluorescence (green) marks lineage-traced keratinocytes. n = 5–6 mice per time point. For the orientation of the histology panels, the wound hole is located at the right of the section and is denoted by “hole.” Unless noted, all histologic images were obtained at 10× magnification. Nuclei are blue from DAPI counterstain. (e) Epidermis; (d) dermis; (c) cartilage; (hf) hair follicle. Data are presented as average ± SEM. Unless noted, all experiments were performed two to three times independently.
Restriction of ectoderm fates in the regenerating ear. (A) Photographs of wounded wild-type and p21−/− mouse ears on days 0 and 28. Representative images were selected from each group. (B) The area of the wounded ear hole measured in wild-type and p21−/− mice on weeks 1, 2, 3, and 4. n = 12–14 mice per group. (*) P < 0.01. The experiment was performed four times independently. (C) Schematic for histology orientation. The red square represents a sample histology section. (D) H&E staining of vertical cross-sections taken from the rim of the wound hole in wild-type and p21−/− mice at day 28. Magnification, 2.5×. Solid vertical lines indicate the ends of the cartilage plate; broken lines demonstrate soft tissue borders. (E) H&E staining of vertical cross-sections taken from the rim of the wound hole in wild-type and p21−/− mice at day 14. (F) Vertical cross-sections of K14CreERmTmG appendages taken from the rim of the wound hole at baseline and 1–4 wk after injury for wild-type and p21−/− mice. GFP fluorescence (green) marks lineage-traced keratinocytes. n = 5–6 mice per time point. For the orientation of the histology panels, the wound hole is located at the right of the section and is denoted by “hole.” Unless noted, all histologic images were obtained at 10× magnification. Nuclei are blue from DAPI counterstain. (e) Epidermis; (d) dermis; (c) cartilage; (hf) hair follicle. Data are presented as average ± SEM. Unless noted, all experiments were performed two to three times independently.We then used keratin-14-CreER (K14CreER) tamoxifen-inducible transgenic mice to map the contribution of the epidermis to the regenerating ear and purify epidermal progeny for molecular analyses. K14CreER mice were crossed with mice harboring mTmG, a double-fluorescent reporter transgene, to produce progeny (K14CreERmTmG) in which Cre recombinase triggers genetic recombination and activation of GFP exclusively in basal keratinocytes. After tamoxifen treatment, GFP expression in wild-type K14CreERmTmG and p21−/− K14CreERmTmG mice was confined to the ectodermal tissues, including dorsal and ventral epidermis, hair follicles, and secretory portions of sebaceous glands (Fig. 1F, top panels). Two-millimeter ear hole punches were performed, and histological analysis of vertical cross-sections taken from the rim of the hole demonstrated that GFP expression remained confined to ectodermal tissues after injury and was absent from mesoderm tissues, including the dermis, cartilage, and blood vessels, up to 16 wk later (Fig. 1F; Supplemental Fig. 1A). This sustained GFP expression suggests that the original tamoxifen-induced cells included epithelial stem cells, since skin keratinocytes had been replaced multiple times over the 4-mo duration of the experiment. Rarely, unlabeled columns appeared in the epidermis, likely reflecting incomplete labeling by Cre recombinase. To rule out a minor contribution from a distinct cell pool, we performed similar lineage tracing experiments with the K14Cre allele, which does not require tamoxifen for activation and marks 100% of keratinocytes with a similar ectoderm-restricted pattern (Supplemental Fig. 1B). Thus, ectoderm regeneration in p21−/− ears originates from pre-existing ectoderm.In addition to skin, endothelial cells and chondrocytes are two major cell types in the ear of MRL and p21−/− mice, and we adopted a similar conditional genetic strategy to lineage-trace and purify these mesoderm-derived descendants. To trace chondrocytes, we intercrossed collagen-2a1-CreER (Col2a1-CreER) tamoxifen-inducible transgenic mice (Nakamura et al. 2006) to create wild-type Col2a1-CreERmTmG and p21−/− Col2a1-CreERmTmG mice. Prior to injury, GFP expression from the mTmG reporter was restricted to chondrocytes (Fig. 2A, top panels). After injury, vertical cross-sections taken from the rim of the ear hole in wild-type Col2a1-CreERmTmG animals demonstrated that GFP expression remained static over 1 mo, and chondrocytes did not regenerate (Fig. 2A, left panels). In p21−/− Col2a1-CreERmTmG animals, we detected a new cluster of GFP+ cells with the morphology and histological appearance of chondrocytes at the center of the regenerating appendage at 2 wk and thereafter (Fig. 2A, right panels, red arrows denote new cartilage generation). These GFP+ cells had increased expression of the cell proliferation marker Ki-67, supporting the view that regenerated ear cartilage arose from expansion of existing chondrocytes (Fig. 2B). In contrast, GFP+ cells were not detected in other tissues, including epidermis, dermis, and blood vessels.
Figure 2.
Restriction of mesoderm fates in the regenerating ear. (A) Vertical cross-sections of Col2-CreERmTmG appendages taken from the rim of the wound hole at baseline and 2–3 wk after injury for wild-type and p21−/− mice. GFP fluorescence (green) marks lineage-traced chondrocytes. The dotted line represents the approximate plane of wounding. Red arrows denote new cartilage generation. n = 5–6 mice per time point. (B) Percentage of chondrocytes expressing Ki-67 in wild-type and p21−/− mice at 4-wk after injury. n = 4 mice per group. (*) P < 0.01. (C) Vertical cross-sections of Tie2CremTmG appendages taken from the rim of the wound hole at 2 wk after injury for wild-type and p21−/− mice. CD31/CD45 cells were stained with Cy5 (red), and GFP fluorescence (green) marks lineage-traced cells. n = 5–6 mice per time point. For orientation of histology panels, the wound hole is located at the right of the section and is denoted by “hole.” Magnification, 10×. Nuclei are blue from DAPI counterstain. (e) Epidermis; (d) dermis; (c) cartilage. Data are presented as average ± SEM. All experiments were performed two to three times independently.
Restriction of mesoderm fates in the regenerating ear. (A) Vertical cross-sections of Col2-CreERmTmG appendages taken from the rim of the wound hole at baseline and 2–3 wk after injury for wild-type and p21−/− mice. GFP fluorescence (green) marks lineage-traced chondrocytes. The dotted line represents the approximate plane of wounding. Red arrows denote new cartilage generation. n = 5–6 mice per time point. (B) Percentage of chondrocytes expressing Ki-67 in wild-type and p21−/− mice at 4-wk after injury. n = 4 mice per group. (*) P < 0.01. (C) Vertical cross-sections of Tie2CremTmG appendages taken from the rim of the wound hole at 2 wk after injury for wild-type and p21−/− mice. CD31/CD45 cells were stained with Cy5 (red), and GFP fluorescence (green) marks lineage-traced cells. n = 5–6 mice per time point. For orientation of histology panels, the wound hole is located at the right of the section and is denoted by “hole.” Magnification, 10×. Nuclei are blue from DAPI counterstain. (e) Epidermis; (d) dermis; (c) cartilage. Data are presented as average ± SEM. All experiments were performed two to three times independently.To assess the contribution of endothelium to the regenerating appendage, we used the Tie2Cre allele to create wild-type Tie2CremTmG and p21−/− Tie2CremTmG mice (Koni et al. 2001). Prior to injury, GFP expression was restricted to endothelium and leukocytes, which was confirmed by immunoassaying sections for platelet endothelial cell adhesion molecule 1 (Pecam1, also called CD31) and the leukocyte marker protein tyrosine phosphatase receptor type C (Ptprc, also called CD45) (Supplemental Fig. 2). A hole punch in the ear is known to induce angiogenesis and recruitment of leukocytes (Park and Barbul 2004; Martin and Leibovich 2005), and, in vertical cross-sections taken from the rim of the wound, we observed an increase in GFP+ cells in both wild-type Tie2CremTmG and p21−/− Tie2CremTmG mice (Fig. 2C; Supplemental Fig. 2). Immunohistology confirmed that nearly all GFP+ cells produced either CD31 or CD45. These findings were also subsequently confirmed by cell purification using fluorescence-activated cell sorting (FACS) (see below). GFP expression was absent in other major tissue types, including epidermis and cartilage. Taken together, these lineage-tracing studies provide compelling evidence that, during ear regeneration in p21−/− mice, keratinocytes, cartilage, and blood vessels derive from corresponding lineage-restricted progenitors.
p21−/− mice fail to induce Sdf1 expression in wound epithelium
The molecular role of p21 in tissue regeneration remains unknown. In addition to appendage regeneration, the absence of p21 improves liver regeneration, and overexpression of p21 induces hepatic fibrosis (Willenbring et al. 2008; Weymann et al. 2009; Aravinthan et al. 2013; Buitrago-Molina et al. 2013;). In a model of chronic liver injury, the genetic deletion of Cxcr4 promoted liver regeneration (Ding et al. 2014). Thus, we postulated that Sdf1–Cxcr4 signaling might be disrupted in p21−/− animals.After 2-mm ear hole punches were performed in wild-type and p21−/− mice, the rim of tissue surrounding the hole was dissected and collected at regular intervals over 1 mo (Fig. 3A). After injury, α-smooth muscle actin mRNA and protein levels as well as collagen levels were significantly decreased in p21−/− mice, indicating a regenerative response rather than accelerated fibrosis (Fig. 3B,C; Supplemental Fig. 3A). Within 3 d of wounding in wild-type mice, Sdf1 mRNA was also induced, but, in p21−/− mice, Sdf1 induction was clearly decreased (Fig. 3D).
Figure 3.
Lack of Sdf1 expression in p21−/− wounded keratinocytes. (A) Cells were isolated from the rim of a wounded ear appendage at different time points. (B) Relative mRNA levels of α-smooth muscle actin (SMA) isolated from the injury rim in wild-type and p21−/− mouse ears at baseline and weeks 1–2. n = 4–5 mice per time point. (*) P < 0.05. (C) Trichome staining on vertical cross-sections of wild-type and p21−/− ear appendages taken from the rim of the wound hole at 1 wk after injury. (Blue) Collagen and cartilage; (red) keratin; (black) nuclei. For orientation, the wound hole is located at the right of the section for all panels. Magnification, 10×. (D) Relative mRNA levels of Sdf1 in the injury rim of wild-type or p21−/− mouse ears. n = 3–4 mice per time point. (*) P < 0.03. (E) Relative mRNA levels of Sdf1 in different cell types isolated from the injury rim in wild-type and p21−/− mice at baseline and week 1. (*) P = 0.005. n = 4–5 mice per time point. (F) SDF1 immunostaining (green) on vertical cross-sections of wild-type and p21−/− mouse ear appendages taken from the rim of the wound hole at 1 wk after injury. For orientation, the wound hole is located at the right of the section for all panels. (G, left panel) Relative mRNA levels of Cdkn1a in wild-type and Cdkn1a knockdown primary human keratinocytes. (Right panel) Relative mRNA levels of Sdf1 in baseline, nutrient-deprived, and hypoxia-treated wild-type and p21−/−
Cdkn1a knockdown keratinocytes. (*) P < 0.005. (H, left panel) Relative mRNA levels of Cebpa in wild-type and Cebpa knockdown mouse embryonic fibroblasts. (*) P < 0.001. (Right panel) Relative mRNA levels of Sdf1 in baseline, nutrient-deprived, and hypoxia-treated wild-type and Cebpa knockdown keratinocytes. (*) P < 0.005; (**) undetectable transcript levels and P < 0.005. Data are presented as average ± SEM. All experiments were performed two to three times independently.
Lack of Sdf1 expression in p21−/− wounded keratinocytes. (A) Cells were isolated from the rim of a wounded ear appendage at different time points. (B) Relative mRNA levels of α-smooth muscle actin (SMA) isolated from the injury rim in wild-type and p21−/− mouse ears at baseline and weeks 1–2. n = 4–5 mice per time point. (*) P < 0.05. (C) Trichome staining on vertical cross-sections of wild-type and p21−/− ear appendages taken from the rim of the wound hole at 1 wk after injury. (Blue) Collagen and cartilage; (red) keratin; (black) nuclei. For orientation, the wound hole is located at the right of the section for all panels. Magnification, 10×. (D) Relative mRNA levels of Sdf1 in the injury rim of wild-type or p21−/− mouse ears. n = 3–4 mice per time point. (*) P < 0.03. (E) Relative mRNA levels of Sdf1 in different cell types isolated from the injury rim in wild-type and p21−/− mice at baseline and week 1. (*) P = 0.005. n = 4–5 mice per time point. (F) SDF1 immunostaining (green) on vertical cross-sections of wild-type and p21−/− mouse ear appendages taken from the rim of the wound hole at 1 wk after injury. For orientation, the wound hole is located at the right of the section for all panels. (G, left panel) Relative mRNA levels of Cdkn1a in wild-type and Cdkn1a knockdown primary human keratinocytes. (Right panel) Relative mRNA levels of Sdf1 in baseline, nutrient-deprived, and hypoxia-treated wild-type and p21−/−
Cdkn1a knockdown keratinocytes. (*) P < 0.005. (H, left panel) Relative mRNA levels of Cebpa in wild-type and Cebpa knockdown mouse embryonic fibroblasts. (*) P < 0.001. (Right panel) Relative mRNA levels of Sdf1 in baseline, nutrient-deprived, and hypoxia-treated wild-type and Cebpa knockdown keratinocytes. (*) P < 0.005; (**) undetectable transcript levels and P < 0.005. Data are presented as average ± SEM. All experiments were performed two to three times independently.To identify the cell types that induce Sdf1, we used GFP marking of cells in our lineage-tracing mouse colonies for FACS to purify specific cell populations for gene expression analysis. This included GFP+ keratinocytes, chondrocytes, endothelial cells, and leukocytes (Supplemental Fig. 3B–E). Consistent with our other observations (Fig. 3D), quantitative RT–PCR (qRT–PCR) revealed that Sdf1 mRNA was significantly induced in wild-type keratinocytes but not p21−/− keratinocytes (Fig. 3E). There was no significant difference in Sdf1 mRNA induction between wild-type and p21−/− chondrocytes, endothelial cells, leukocytes, or the sorted K14CreER GFPneg population, which includes mesenchymal cells (Fig. 3E; Supplemental Fig. 4A). We used in situ hybridization to confirm that Sdf1 mRNA was induced in wild-type keratinocytes but not p21−/− keratinocytes (Supplemental Fig. 4B). Protein immunohistochemistry also localized the majority of Sdf1 expression to keratinocytes at the wounded edge, with some minor Sdf1 expression in the dermis (Fig. 3F; Supplemental Fig. 4C). In summary, we conclude that ear injury in wild-type animals induces Sdf1 expression in wound epidermis, and Sdf1 induction is dependent on p21.
p21 regulation of Sdf1 expression
p21 regulates gene expression in specific contexts by acting as a coactivator or corepressor (Abbas and Dutta 2009). p21 also interacts directly with the transcription factor C/EBPα to regulate gene expression (Timchenko et al. 1997; Harris et al. 2001). In silico analysis of the human Sdf1 promoter identified an evolutionarily conserved binding site for C/EBPα, and we tested whether C/EBPα regulates Sdf1 expression (Yu et al. 2011; Mathelier et al. 2014). Cells adjacent to wounded areas are often deprived of nutrients and experience hypoxia, which are two common cell culture methods to induce Sdf1. We used shRNA to knock down p21 or CEBPα transcript levels in human keratinocytes (Fig. 3G,H, left panels). Consistent with our in vivo experiments, nutrient deprivation or exposure to hypoxia significantly induced Sdf1 mRNA expression in wild-type keratinocytes but not p21 knockdown cells (Fig. 3G, right panel). Similarly, nutrient deprivation or exposure to hypoxia did not induce Sdf1 significantly in C/EBPα knockdown keratinocytes (Fig. 3H, right panel). Consistent with these observations, coimmunoprecipitation studies showed that p21 and CEBPα interact directly in human keratinocytes (Supplemental Fig. 5A). Prior work has also shown that p21 can regulate Sdf1 expression via increased Stat3 activity during vascular wound repair (Olive et al. 2008), but we did not detect significant differences of Stat3 signaling in the injured ears of wild-type and p21−/− animals (Supplemental Fig. 5B). Thus, we conclude that p21 interacts with C/EBPα to regulate Sdf1 gene expression.
Reduced recruitment of Cxcr4+ leukocytes in p21−/− mice
Cxcr4 is an established receptor for Sdf1, and, in response to injury, Sdf1 recruits Cxcr4+ cells for tissue repair (Tögel et al. 2005; Kitaori et al. 2009). In the rim of ear tissue surrounding the hole, Cxcr4 mRNA transcript and protein were up-regulated in wild-type mice, and this induction was clearly reduced in p21−/− mice (Fig. 4A,B). Two possibilities for elevated Cxcr4 expression in the rim tissue were (1) recruitment of additional Cxcr4+ cells and (2) increased Cxcr4 expression by constituent cells.
Figure 4.
Failure of Cxcr4+ leukocyte recruitment to the wound rim in p21−/− mice. (A,B) Relative mRNA levels (A) and protein levels (B) of Cxcr4 in the injury rim of wild-type and p21−/− mouse ears at the indicated times. n = 4–5 mice per time point. (*) P < 0.01. (C) GFP+ cells from Tie2CremTmG mice were isolated and further divided into CD45+ leukocyte and CD45neg endothelial cell fractions. Relative mRNA levels of Cxcr4 were compared between wild-type and p21−/− mice at baseline (BL) and 1 wk after injury. (D) Relative mRNA levels of Cxcr4 in endothelial cells (EC) and leukocytes (WBC). n = 6–7 samples per group. (*) P < 0.02. (E) CD45 and CXCR4 immunostaining on vertical cross-sections taken from the rim of the wound hole in wild-type and p21−/− mouse appendages at 1 wk after injury. For orientation, the wound hole is located at the right of the section for all panels. (F) Percentage of leukocytes, T cells, and endothelial cells in the total population of sorted cells from the rim of a wounded ear in wild-type and p21−/− mice at 1 wk after injury. n = 4–8 per treatment group. (*) P < 0.04. Data are presented as average ± SEM. All experiments were performed two to three times independently.
Failure of Cxcr4+ leukocyte recruitment to the wound rim in p21−/− mice. (A,B) Relative mRNA levels (A) and protein levels (B) of Cxcr4 in the injury rim of wild-type and p21−/− mouse ears at the indicated times. n = 4–5 mice per time point. (*) P < 0.01. (C) GFP+ cells from Tie2CremTmG mice were isolated and further divided into CD45+ leukocyte and CD45neg endothelial cell fractions. Relative mRNA levels of Cxcr4 were compared between wild-type and p21−/− mice at baseline (BL) and 1 wk after injury. (D) Relative mRNA levels of Cxcr4 in endothelial cells (EC) and leukocytes (WBC). n = 6–7 samples per group. (*) P < 0.02. (E) CD45 and CXCR4 immunostaining on vertical cross-sections taken from the rim of the wound hole in wild-type and p21−/− mouse appendages at 1 wk after injury. For orientation, the wound hole is located at the right of the section for all panels. (F) Percentage of leukocytes, T cells, and endothelial cells in the total population of sorted cells from the rim of a wounded ear in wild-type and p21−/− mice at 1 wk after injury. n = 4–8 per treatment group. (*) P < 0.04. Data are presented as average ± SEM. All experiments were performed two to three times independently.Assessing for Cxcr4 expression in our panel of FACS-purified cell populations, we discovered that Cxcr4 mRNA was not reproducibly detected in wild-type or p21−/− keratinocytes or chondrocytes (data not shown). In contrast, wounding induced Cxcr4 mRNA expression in GFP+ cells from Tie2CremTmG animals in a p21-dependent fashion (Fig. 4C, left panel). Tie2Cre is expressed in leukocytes and endothelial cells. To identify the responsible cell types, we further purified the GFP+ population into leukocytes (GFP+CD45+) and endothelial cells (GFP+CD45neg) and discovered that Cxcr4 was not induced in either cell type (Fig. 4C, right panel). The basal level of Cxcr4 mRNA is ∼14-fold higher in leukocytes compared with endothelial cells (Fig. 4D), which suggests that recruitment of additional Cxcr4+ cells to the wounded ear may be responsible for the induction of Cxcr4.Immunohistochemistry demonstrated increased recruitment of CD45+ and Cxcr4+ cells in wild-type mice to the dermal compartment compared with p21−/− mice (Fig. 4E). Moreover, we quantified the number of cells in the wounded ear by FACS and found an approximately threefold increase of leukocytes (GFP+CD45+) and, more specifically, T cells (GFP+CD45+CD3+) in the wounded ears of wild-type Tie2CremTmG mice compared with p21−/− Tie2CremTmG mice (Fig. 4F). In contrast, there was no significant difference in the number of endothelial cells at the injured rim between wild-type and p21−/− animals. Taken together, our data indicate that the increased level of Cxcr4 mRNA in the injured ear rim reflects increased recruitment of Cxcr4+ leukocytes to the wounded area in wild-type mice. Consistent with these observations, we observed ear regeneration following hole punch in leukocyte-deficient nude mice that was indistinguishable in appearance and tempo from that observed in p21−/− and MRL mice (Supplemental Fig. 6), corroborating prior findings (Gawronska-Kozak 2004).
Pharmacologic or genetic inhibition of Sdf1–Cxcr4 signaling promotes ear regeneration
AMD3100 (Plerixafor) is a specific and well-characterized inhibitor of Cxcr4 in current clinical use (Hendrix et al. 2004). Based on our finding that diminished Sdf1–Cxcr4 signaling in p21−/− mice promoted tissue regeneration, we hypothesized that disruption of Sdf1–Cxcr4 signaling in wild-type animals with AMD3100 might promote tissue regeneration after ear hole punch. We delivered AMD3100 or vehicle control (PBS) systemically to wild-type mice via subcutaneous osmotic pump. Compared with control animals, ear holes in AMD3100-treated wild-type mice regenerated strikingly better (Fig. 5A,B). After injury, levels of α-smooth muscle actin mRNA and collagen expression in the ear hole tissue were also significantly decreased in AMD3100-treated mice, consistent with a regenerative response rather than accelerated fibrosis (Fig. 5C,E). As expected, induction of Sdf1 mRNA was similar in the ear hole rim tissue from both control and AMD3100-treated animals, but the amount of Cxcr4 mRNA was significantly decreased in AMD3100-treated animals and similar to the decreased Cxcr4 mRNA levels seen in p21−/− mice (Fig. 5D). Gross and histological analysis of the injury rim in PBS control animals revealed healed epidermis without significant areas of hyperplasia, and there was no evidence of cartilage regeneration (Fig. 5E). In contrast, the rim of AMD3100-treated mice showed epidermal hyperplasia, thickened dermis, and islands of new cartilage (Fig. 5E, black arrow), changes similar to regenerating MRL and p21−/− ears (Fig. 1D). Similar to p21−/− mice, AMD3100 treatment of wild-type mice increased the expression of Ki-67 in chondrocytes from 1% to 30% (Fig. 5F). Finally, our data suggest that, after injury, Cxcr4+ cells were recruited to the injury site during the first week, and this recruitment diminished by 2–3 wk (Fig. 4A). To test whether a shorter AMD3100 treatment interval was sufficient to restore tissue regeneration, we delivered AMD3100 (or vehicle PBS control) to wild-type mice for only 1 wk after wounding. Compared with control animals, ear hole closure in AMD3100-treated wild-type mice was also significantly improved (Fig. 5G).
Figure 5.
Genetic or pharmacologic inhibition of Sdf1–Cxcr4 signaling in wild-type mice promotes tissue regeneration. (A) Photographs of control and AMD3100-treated mouse ears at week 4. (B) The area of the hole in the wounded ear at the indicated times for control and AMD3100 treatment groups. n = 8–9 for each treatment group. (*) P < 0.003. (C) Relative mRNA levels of α-smooth muscle actin (SMA) at day 4 for each treatment group. n = 3–4 for each treatment group. (*) P < 0.001. (D) Relative mRNA levels of Sdf1 and Cxcr4 at day 4 for each treatment group. n = 3–4 for each treatment group. (*) P = 0.04. (E) Trichrome staining of vertical cross-sections taken from the rim of the wound hole in control and AMD3100-treated appendages on day 14. (Blue) Collagen and cartilage; (red) keratin; (black) nuclei. The black arrow indicates new cartilage synthesis. The dotted line represents the approximate plane of wounding. Magnification, 10×. (F) The percentage of chondrocytes expressing Ki-67 for each treatment group. (*) P = 0.02. (G) The area of the hole in the wounded ear at the indicated times for control and 1-wk AMD3100 pulse treatment groups. n = 8–9 for each treatment group. (*) P < 0.01. (H, left panel) Relative mRNA levels of Cxcr4 in hearts and ears isolated from untreated and tamoxifen-treated Cxcr4f/f Rosa26CreERT2 mice. n = 3 for each treatment group. (Right panel) The area of the hole in the wounded ear at the indicated times in untreated and tamoxifen-treated Cxcr4f/f Rosa26CreERT2 mice. n = 7–8 for each treatment group. (*) P < 0.01. Data are presented as average ± SEM. Representative images were selected for each group. All experiments were performed two to three times independently.
Genetic or pharmacologic inhibition of Sdf1–Cxcr4 signaling in wild-type mice promotes tissue regeneration. (A) Photographs of control and AMD3100-treated mouse ears at week 4. (B) The area of the hole in the wounded ear at the indicated times for control and AMD3100 treatment groups. n = 8–9 for each treatment group. (*) P < 0.003. (C) Relative mRNA levels of α-smooth muscle actin (SMA) at day 4 for each treatment group. n = 3–4 for each treatment group. (*) P < 0.001. (D) Relative mRNA levels of Sdf1 and Cxcr4 at day 4 for each treatment group. n = 3–4 for each treatment group. (*) P = 0.04. (E) Trichrome staining of vertical cross-sections taken from the rim of the wound hole in control and AMD3100-treated appendages on day 14. (Blue) Collagen and cartilage; (red) keratin; (black) nuclei. The black arrow indicates new cartilage synthesis. The dotted line represents the approximate plane of wounding. Magnification, 10×. (F) The percentage of chondrocytes expressing Ki-67 for each treatment group. (*) P = 0.02. (G) The area of the hole in the wounded ear at the indicated times for control and 1-wk AMD3100 pulse treatment groups. n = 8–9 for each treatment group. (*) P < 0.01. (H, left panel) Relative mRNA levels of Cxcr4 in hearts and ears isolated from untreated and tamoxifen-treated Cxcr4f/f Rosa26CreERT2 mice. n = 3 for each treatment group. (Right panel) The area of the hole in the wounded ear at the indicated times in untreated and tamoxifen-treated Cxcr4f/f Rosa26CreERT2 mice. n = 7–8 for each treatment group. (*) P < 0.01. Data are presented as average ± SEM. Representative images were selected for each group. All experiments were performed two to three times independently.Our results with AMD3100 predicted that genetic disruption of Sdf1–Cxcr4 signaling in vivo should also promote ear regeneration. Since mice lacking Cxcr4 die in embryogenesis, we used the conditional Cxcr4f/f strain to disrupt Sdf1–Cxcr4 signaling (Tachibana et al. 1998). We intercrossed Cxcr4f/f mice with Rosa26CreERT2 to permit efficient tamoxifen-induced conditional inactivation of Cxcr4 in all tissues except brain (Fig. 5H, left panel). Compared with untreated mice, holes in tamoxifen-treated Rosa26CreER Cxcr4f/f mice regenerated better (Fig. 5H, right panel). Thus, pharmacologic or genetic disruption of Sdf1–Cxcr4 signaling induced appendage regeneration.
Discussion
The ability to regenerate lost organs following trauma is one of the great unsolved mysteries in medical research, and understanding the basis of mammalian regenerative biology is relevant to human regenerative medicine. In response to injury, wounded wild-type keratinocytes induce the expression of Sdf1, a known chemokine for Cxcr4+ leukocytes (Fig. 6, left panel). In p21−/− animals, Sdf1 induction is markedly diminished, and fewer Cxcr4+ leukocytes are recruited (Fig. 6, right panel). Similar to p21−/− animals, genetic or pharmacologic disruption of Sdf1–Cxcr4 signaling promoted tissue regeneration. Regeneration of full tissue architecture without scarring argues that increased healing is not the effect of wound contraction, a distinct process that can improve wound healing but invariably results in fibrosis.
Figure 6.
Chemokine signals from wound epidermis regulate tissue regeneration in mice. (Left panel) An illustration depicting how wounded wild-type keratinocytes induce Sdf1 to recruit Cxcr4+ leukocytes to promote fibrosis and scar formation. (Right panel) In wounded p21−/− animals, Sdf1 induction is markedly diminished, and fewer Cxcr4+ leukocytes are recruited, thereby permitting lineage-restricted tissue regeneration. Genetic or pharmacologic disruption of Sdf1–Cxcr4 signaling enhances tissue repair.
Chemokine signals from wound epidermis regulate tissue regeneration in mice. (Left panel) An illustration depicting how wounded wild-type keratinocytes induce Sdf1 to recruit Cxcr4+ leukocytes to promote fibrosis and scar formation. (Right panel) In wounded p21−/− animals, Sdf1 induction is markedly diminished, and fewer Cxcr4+ leukocytes are recruited, thereby permitting lineage-restricted tissue regeneration. Genetic or pharmacologic disruption of Sdf1–Cxcr4 signaling enhances tissue repair.Our lineage tracing results demonstrate that lineage-restricted precursor cells for epidermis, cartilage, and endothelium, rather than oligopotent cells, work in concert to regenerate the p21−/− appendage. Within the same species, different organs can use distinct modes of tissue regeneration. In salamanders, tails regenerate from oligopotent cells, while limbs regenerate from lineage-restricted precursor cells (Echeverri and Tanaka 2002; Kragl et al. 2009). Our lineage findings are reminiscent of studies in mammalian digit regeneration and suggest that mammalian appendages regenerate from lineage-restricted precursor cells. We cannot rule out the possibility that appendage regeneration reflects the function of an as yet undetected oligopotent cell type induced by injury. For example, it remains possible that dermal mesenchymal cells may promote regeneration, a possibility that may be tested once reliable Cre recombinase alleles for lineage-tracing these cells in vivo are available. It will also be important to continue to study other variables that may influence mammalian tissue regeneration, including the mode of injury.The hypothesis that wound epidermis initiates or regulates tissue regeneration has been suggested in other species. In salamanders, the absence of the wound epidermis prevents limb regeneration (Thornton 1957; Carlson 2007). Deer antlers regenerate annually, but antlerogenesis is lost if the skin overlying the antler bone pedicle is removed and replaced with a full-thickness skin graft (Goss 1995). These findings suggest a two-way interaction between the overlying skin and underlying skeletal tissues and cell types to coordinate tissue regeneration. Our identification of p21-dependent Sdf1 production by keratinocytes at the wounded edge is consistent with this possibility. Further localization of this effect may benefit from studies of mice with conditional p21 knockout alleles, when available. How multiple tissue-specific precursor cells expand and collaborate to restore integrated tissue architecture and function also remains to be defined.Prior studies in digit tip regeneration have suggested that bone morphogenetic proteins like BMP2 activate Sdf1–Cxcr4 signaling in endothelial cells to promote digit tip regeneration (Lee et al. 2013). This result contrasts with our findings and other studies in the liver and lung, where the absence of Sdf1–Cxcr4 signaling promotes tissue regeneration. One possibility is Sdf1–Cxcr4 signaling in tissue regeneration may be cell type-specific or injury context-specific. BMP2 signaling is thought to primarily drive bone regeneration, and the lung, liver, and the outer ear lack bone. Consistent with this possibility, we do not see induction of BMP2 in the rim of regenerating appendages (TH Leung and SK Kim, unpubl.).A reduced capacity to regenerate tissues has been correlated with the appearance of adaptive immunity in evolution (Mescher and Neff 2005). At sites of injury, stereotyped programs of recruitment and influx of immune cells (neutrophils, macrophages, and lymphocytes) are critical to prevent microbial infection and debride the wound (Park and Barbul 2004; Martin and Leibovich 2005). While immune cell recruitment is required to initiate early wound-healing responses, previous studies have demonstrated that some forms of immunosuppression can accelerate subsequent regeneration (Forbes and Rosenthal 2014). In humans, fetal skin regenerates after injury without scarring (unlike adult wound healing), a phenomenon accompanied by reduced immune cell infiltration and decreased inflammation (Rolfe and Grobbelaar 2012). In our studies, we found that decreased Sdf1 expression and diminished recruitment of Cxcr4+ leukocytes promote tissue regeneration. Our results may also explain the statistically significant linkage of the locus containing Sdf1 to regeneration in QTL studies of MRL mice (Cheverud et al. 2012). The balance between inflammatory responses and tissue regeneration is likely to be complex and multiphasic. Further studies are needed to investigate the subsets of wound Cxcr4+ leukocytes recruited by Sdf1 and understand how these cells normally promote wound healing, fibrosis, and scar formation.We showed that Sdf1 mRNA induction requires p21 and C/EBPα in keratinocytes. Consistent with this view, prior studies showed that disruption of C/EBPα enhances tissue regeneration in multiple tissues. For example, knockdown of C/EBPα reduced injury-induced leukocyte infiltration and improved cardiac tissue regeneration (Huang et al. 2012). After partial hepatectomy, suppression of hepatic C/EBPα expression leads to an enhanced regenerative response (Greenbaum et al. 1995). Taken together, we speculate that p21 and C/EBPα collaborate to increase Sdf1 expression in the injured wild-type ear, which leads to recruitment of Cxcr4-expressing leukocytes and fibrosis, thereby limiting regeneration.Using AMD3100, an established antagonist of Cxcr4 signaling, we induced appendage regeneration in wild-type animals. In the past, AMD3100, either by itself or in combination with platelet-derived growth factor or tacrolimus (Allen et al. 2014; Lin et al. 2014), improved wound healing and scar formation in diabetic mice (Nishimura et al. 2011) and mice receiving thermal burns (Avniel et al. 2005). Here we show that AMD3100 treatment promotes tissue regeneration and restores normal tissue structure and function after injury in a scarless manner. Currently, short courses of AMD3100 are used to mobilize bone marrow stem cells for transplantation in humans, and a common side effect of AMD3100 is peripheral blood leukocytosis (Hübel et al. 2004). Similar to results in mouse digit regeneration, our lineage tracing experiments suggest that hematopoietic stem cells do not contribute to ear regeneration (Lehoczky et al. 2011; Rinkevich et al. 2011). We speculate that the peripheral blood leukocytosis seen in patients may also result from disruption of Sdf1-mediated leukocyte trafficking, and future studies are needed to understand this mechanism more precisely. Collectively, our observations suggest that the clinical uses of AMD3100 may be expanded to include treatment of traumatic appendage wounds or chronic nonhealing wounds in skin. These are common problems that lack effective treatments and represent an important unmet need in current clinical practice.
Materials and methods
Animals
Wild-type, p21−/−, Cxcr4f/f, mTmG reporter, K14-Cre, K14-CreER, Tie-2Cre, Col2CreER, Rosa26-CreER, and J:NU mouse strains were obtained from Jackson Laboratory (strains 101045, 3263, 8767, 7676, 4782, 5107, 4128, 6774, 8463, and 7850, respectively). Mice were verified with genotyping instructions provided by Jackson Laboratory. For the ear wounding, we used a standard 2-mm mechanical punch to create a hole in the center of each outer ear (pinna) (Roboz). To delete reporter alleles, we administered 1 mg of tamoxifen (diluted in corn oil) daily by intraperitoneal injection for 5–10 d, depending on the Cre line. For Cxcr4f/f mice, tamoxifen was administered for 5 d and then every other day for 1 mo. Mice used in this study were female age-matched littermates. All mice were housed in the animal facility of Stanford University on a 12-h light/dark cycle with ad libitum access to water and normal chow.
Cell sorting
Freshly dissected tissue from the rim of healing appendages were manually dissociated with scissors and then incubated with liberase (Roche) for 60 min at 37°C. After dissociation, cells were washed in PBS and resuspended in FACS buffer (HBSS, 0.2% BSA, 1% HEPES). 7-AAD (BioLegend) was added to exclude dead cells. FACS was performed on a FACS Aria II (BD Biosciences). Standard FACS procedures were performed; all positive sorting gates were based on negative gates, and compensation was carried out to remove spectral overlap. Sorted cells were immediately harvested for RNA purification and real-time RT–PCR analysis. The following primary antibodies were used: anti-mouse CD3 antibody (BioLegend) and anti-mouse CD45 antibody (BioLegend).
Histology, in situ hybridization, and immunohistochemistry
Standard histology and immunostaining protocols (including H&E and Trichome) were performed. Briefly, immunohistochemical analysis was performed on 5- to 10-μm-thick sections of mouse skin. The following primary antibodies were used: mouse monoclonal anti-Ki-67 (1:100; Novocastra), rabbit polyclonal anti-GFP (1:200; Abcam), rabbit polyclonal anti-Sdf1 (1:100; Abcam), mouse monoclonal anti-α smooth muscle actin (1:100; Abcam), rabbit polyclonal anti-CD31 (1:100; Abcam), rat anti-mouse CD45 (1:100; BioLegend), and rabbit polyclonal anti-Cxcr4 (1:100; Abcam). Immune complexes were detected with secondary antibodies conjugated with either Cy3, Cy5, fluorescein isothiocyanate (Jackson ImmunoResearch), or horseradish peroxidase (Vector Laboratories). In situ hybridization on Cxcl12 was performed per the manufacturer's instructions (Advanced Cell Diagnostics); a positive control probe was directed against RNA polymerase, and a negative control probe was directed against bacterial DapB. After staining, images were directly analyzed on an AxioM1 microscope equipped with a CCD digital camera (Carl Zeiss). The number of Ki-67+ cells was counted for every 250 μm of cartilage, measured at the distal tip, for each sample. A minimum of four different samples was used for each time point and then averaged.
AMD3100 osmotic pump experiments
After equilibrating an osmotic pump (Alzet, model 2004) in PBS for 36 h, we inserted AMD3100 dissolved in PBS into the pump and implanted the pump subcutaneously into the back of the mouse. The pump released ∼8 mg of AMD3100 per kilogram of body weight per day (Shu et al. 2013).
Real-time RT–PCR
Cells for RT–PCR analysis were collected in Trizol (Invitrogen). Total RNA was isolated by Direct-Zol RNA Miniprep (Zymo). RNA concentration was measured by Nanodrop 1000 (Thermo Scientific). cDNA synthesis was performed with Maxima Reverse Transcriptase (Thermo Scientific) per the manufacturer's instructions. One-step quantitative RT–PCR was performed and analyzed using an ABI Prism 7300 detection system (Applied Biosystems) with TaqMan one-step RT–PCR Master Mix reagents or SYBR Green one-step RT–PCR Master Mix reagents (Applied Biosystems). TaqMan probes were purchased for mouse genes (Acta2, Cxcr4, Cxcl12, Cdkn1a, Cebpa, β-actin, Krt10, Col2a, Pecam, and Ptprc; Life Technologies).
Western blot analysis
Total protein was prepared from mouse ear tissue by direct application of SDS sample buffer and mechanical tissue disruption. Equal amounts of protein were resolved on SDS-PAGE and transferred to nitrocellulose membranes (Bio-Rad) for immunoblotting with specific antibodies, including rabbit polyclonal anti-Cxcr4 (1:1000; Abcam), rabbit monoclonal anti-Stat3 (1:1000; Cell Signaling Technology, 4904P), rabbit monoclonal anti-Phospho-Stat3 (1:1000; Cell Signaling Technology, 9145), rabbit polyclonal anti-p21 (1:1000; Santa Cruz Biotechnology), rabbit polyclonal anti-CEBPα (1:1000; Santa Cruz Biotechnology), and rabbit polyclonal anti-β-actin-HRP (1:1000; Santa Cruz Biotechnology). After further incubation with HRP-conjugated secondary antibodies, signal was visualized using ECL detection (Amersham Pharmacia) on Kodak film or Gel Doc XR+ system (Bio-Rad). For the CEBPα immunoprecipitation, samples were run on a Wes (Proteinsimple) per the manufacturer's instructions with a mouse monoclonal anti-p21 antibody (Santa Cruz Biotechnology).
Cell culture
Primary human keratinocytes were obtained from the University of Pennsylvania Skin Disease Resource Center. They were grown and passaged as previously described (Leung et al. 2013). We obtained lentiviral knockdown vectors from The RNAi Consortium shRNA Library for Cdkn1a (TRCN287021) and CEBPα (TRCN7304). Lentivirus was produced as previously described (Leung et al. 2004). After selection, keratinocytes were seeded at 300,000 per well in six-well plates. On the following day, cells were deprived of nutrients for 24 h (keratinocyte media with no supplements) or exposed to 1.5% O2 for 48 h.
Immunoprecipitation
Briefly, hypoxia-treated keratinocytes were lysed in a nondenaturing lysis buffer (20 mM Tris at pH 8.0, 137 mM NaCl, 1% Nonidet P-40, 2 mM EDTA) supplemented with protease and phosphatase inhibitors (Roche) at 4°C. Lysates were precleared with protein G beads (Invitrogen). Cell lysate (500 μg) was incubated overnight with primary antibodies, including mouse monoclonal anti-p21 and rabbit polyclonal anti-CEBPa (Santa Cruz Biotechnology), and protein-G beads were added for the last 2 h. The immunoprecipitates were washed three times with lysis buffer and eluted with SDS buffer. Western analysis was performed as described.
Statistics
A two-tailed Student's t-test was used to determine significance, with P values of <0.05 considered significant. Higher levels of significance (P < 0.01 and P < 0.001) are indicated in the text.
Study approval
Experiments involving mice were reviewed and approved by the Institutional Animal Care and Use Committee of Stanford University. Mice were treated in accordance with the National Institutes of Health guidelines for the humane care of animals.
Authors: Qing Lin; Russell N Wesson; Hiromichi Maeda; Yongchun Wang; Zhu Cui; Jun O Liu; Andrew M Cameron; Bin Gao; Robert A Montgomery; George M Williams; Zhaoli Sun Journal: J Invest Dermatol Date: 2014-03-28 Impact factor: 8.551
Authors: Bi-Sen Ding; Zhongwei Cao; Raphael Lis; Daniel J Nolan; Peipei Guo; Michael Simons; Mark E Penfold; Koji Shido; Sina Y Rabbany; Shahin Rafii Journal: Nature Date: 2013-11-20 Impact factor: 49.962
Authors: Maksim V Plikus; Christian F Guerrero-Juarez; Mayumi Ito; Yun Rose Li; Priya H Dedhia; Ying Zheng; Mengle Shao; Denise L Gay; Raul Ramos; Tsai-Ching Hsi; Ji Won Oh; Xiaojie Wang; Amanda Ramirez; Sara E Konopelski; Arijh Elzein; Anne Wang; Rarinthip June Supapannachart; Hye-Lim Lee; Chae Ho Lim; Arben Nace; Amy Guo; Elsa Treffeisen; Thomas Andl; Ricardo N Ramirez; Rabi Murad; Stefan Offermanns; Daniel Metzger; Pierre Chambon; Alan D Widgerow; Tai-Lan Tuan; Ali Mortazavi; Rana K Gupta; Bruce A Hamilton; Sarah E Millar; Patrick Seale; Warren S Pear; Mitchell A Lazar; George Cotsarelis Journal: Science Date: 2017-01-05 Impact factor: 47.728
Authors: Jenny J Wei; Hali S Kim; Casey A Spencer; Donna Brennan-Crispi; Ying Zheng; Nicolette M Johnson; Misha Rosenbach; Christopher Miller; Denis H Leung; George Cotsarelis; Thomas H Leung Journal: Sci Immunol Date: 2020-08-28